Science Explorer Back to mapMap
Discussion
Researcher · F-star (United Kingdom) · United Kingdom

Michelle Morrow

Michelle Morrow publishes mostly in Oncology, Immunology and Molecular Biology, on topics such as Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses and Monoclonal and Polyclonal Antibodies Research.

ORCID 0000-0002-4565-2008 OpenAlex
World rank
#445,839
of 7,710,434 ranked researchers
Rank in United Kingdom
#39,164
of 367,258
Works
183
Citations
4k
Citations per work
21.7
h-index
19
i10-index 27Top 25% in Oncology
Michelle Morrow

What does Michelle Morrow research?

Michelle Morrow's work is mostly in Medicine (42%), Immunology and Microbiology (19%), Biochemistry, Genetics and Molecular Biology (16%).

Health Sciences: 77 works · 42.2% of their workMedicine: 77 works · 42.2% of their workOncology: 51 works · 28.1% of their workRadiology, Nuclear Medicine and Imaging: 18 works · 10.0% of their workHematology: 8 works · 4.1% of their workLife Sciences: 64 works · 34.9% of their workImmunology and Microbiology: 34 works · 18.6% of their workImmunology: 34 works · 18.6% of their workBiochemistry, Genetics and Molecular Biology: 30 works · 16.3% of their workMolecular Biology: 22 works · 11.8% of their workCancer Research: 8 works · 4.5% of their workEverything else: 42 works · 22.9% of their workTHEIR WORKMichelle Morrow183works
Life Sciences35%Health Sciences42%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine7742.2%
    1. Immunology and Microbiology3418.6%
    2. Biochemistry, Genetics and Molecular Biology3016.3%
  3. Everything else4222.9%
  1. 1Oncology28% of their works
  2. 2Immunology19% of their works
  3. 3Molecular Biology12% of their works
  4. 4Radiology, Nuclear Medicine and Imaging10% of their works
  5. 5Cancer Research4% of their works
  6. 6Hematology4% of their works

Research topics

Which keywords describe Michelle Morrow's research?

The keywords of their largest research topics: Tumor Microenvironment, Immune Checkpoint Blockade, PD-1 and PD-L1, Cancer Immunotherapy, Immunity, Antigen Presentation, Dendritic Cells and Fc Receptors.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Tumor Microenvironment462 topics
  2. Immune Checkpoint Blockade381 topic
  3. PD-1 and PD-L1381 topic
  4. Cancer Immunotherapy302 topics
  5. Immunity242 topics
  6. Antigen Presentation181 topic
  7. Dendritic Cells181 topic
  8. Fc Receptors151 topic
  9. Therapeutic Antibodies151 topic
  10. CAR T Cells121 topic
  11. Chimeric Antigen Receptor121 topic
  12. Fibroblast Activation Protein81 topic
  13. Immunosuppression81 topic
  14. NK Cell Recognition81 topic
  15. Natural Killer Cells81 topic
  16. Activation61 topic
  17. Foxp361 topic
  18. Macrophage61 topic
  19. TGF-ß61 topic

Where does Michelle Morrow work?

Michelle Morrow's main affiliation in the publication record is F-star (United Kingdom), United Kingdom.

How many publications and citations does Michelle Morrow have?

OpenAlex counts 183 works and 3,970 citations for Michelle Morrow, an h-index of 19, ranking #445,839 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Michelle Morrow. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.